{"organizations": [], "uuid": "26c9109afca67dba2fe7d2858477554cdd8ba7e6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-woodford-investment-says-will-be-w/brief-woodford-investment-says-will-be-working-with-prothena-corp-on-its-strategy-beyond-its-pronto-trial-investigating-neod001-in-al-amyloidosis-idUSFWN1S0115", "country": "US", "domain_rank": 408, "title": "BRIEF-Woodford Investment Says Will Be Working With Prothena Corp On Its Strategy Beyond Its Pronto Trial Investigating NEOd001 In Al Amyloidosis", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-23T16:39:00.000+03:00", "replies_count": 0, "uuid": "26c9109afca67dba2fe7d2858477554cdd8ba7e6"}, "author": "", "url": "https://www.reuters.com/article/brief-woodford-investment-says-will-be-w/brief-woodford-investment-says-will-be-working-with-prothena-corp-on-its-strategy-beyond-its-pronto-trial-investigating-neod001-in-al-amyloidosis-idUSFWN1S0115", "ord_in_thread": 0, "title": "BRIEF-Woodford Investment Says Will Be Working With Prothena Corp On Its Strategy Beyond Its Pronto Trial Investigating NEOd001 In Al Amyloidosis", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "prothena corp", "sentiment": "negative"}, {"name": "al amyloidosis reuters staff", "sentiment": "none"}, {"name": "prothena corporation plc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News April 23, 2018 / 1:40 PM / Updated 30 minutes ago BRIEF-Woodford Investment Says Will Be Working With Prothena Corp On Its Strategy Beyond Its Pronto Trial Investigating NEOd001 In Al Amyloidosis Reuters Staff 1 Min Read \nApril 23 (Reuters) - Prothena Corporation PLC: \n* WOODFORD INVESTMENT MANAGEMENT SAYS WILL BE WORKING WITH PROTHENA CORP ON ITS STRATEGY BEYOND ITS PRONTO TRIAL INVESTIGATING NEOD001 IN AL AMYLOIDOSIS Source text: ( bit.ly/2HRH9mk ) Further company coverage: (Reuters.Briefs@thomsonreuters.com)", "external_links": [], "published": "2018-04-23T16:39:00.000+03:00", "crawled": "2018-04-23T17:05:54.011+03:00", "highlightTitle": ""}